Concepedia

Jonathan Treisman

JT

Statistics

Publications

21

Citations

2.2K

H-Index

16

Active since

1990

Affiliations

National Cancer Institute(Current)

National Institutes of Health

Aurora St. Luke's Medical Center

Weizmann Institute of Science

The University of Texas MD Anderson Cancer Center

Jonathan Treisman is an author at National Cancer Institute specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1990–2023

21

Publications

21

gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma

Douglas J. Schwartzentruber, David H. Lawson, Jon Richards et al. · New England Journal of Medicine · 2011 · 878 citations

Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.

Jeffrey S. Weber, Michael L. Salgaller, Dvorit Samid et al. · PubMed · 1994 · 296 citations

, , +17

In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes.

Patrick Hwu, James C. Yang, R Cowherd et al. · PubMed · 1995 · 275 citations

, , +17

Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain.

Patrick Hwu, GE Shafer, Jonathan Treisman et al. · The Journal of Experimental Medicine · 1993 · 256 citations · Full text

, , +15

Interleukin-2-transduced lymphocytes grow in an autocrine fashion and remain responsive to antigen

Jonathan Treisman, Patrick Hwu, Seijiro Minamoto et al. · Blood · 1995 · 71 citations · Full text

1–5 of 21